MedPath
HSA Approval

SUGAMMADEX SCIGEN SOLUTION FOR INJECTION 100MG/ML

SIN16933P

SUGAMMADEX SCIGEN SOLUTION FOR INJECTION 100MG/ML

SUGAMMADEX SCIGEN SOLUTION FOR INJECTION 100MG/ML

January 23, 2024

SCIGEN PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSCIGEN PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

V03AB35

sugammadex

Manufacturer Information

SciGen Pte Ltd.

MEFAR İLAÇ SANAYII A.Ş.

Active Ingredients

Sugammadex Sodium eqv Sugammadex

100mg/ml

Sugammadex

Documents

Package Inserts

Sugammadex SciGen Solution for Injection 100 mg_ml PI.pdf

Approved: January 23, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SUGAMMADEX SCIGEN SOLUTION FOR INJECTION 100MG/ML - HSA Approval | MedPath